Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Payne

Showing results (411-420 of 441) with videos related to

Pageof 45
Sort By:
Epilepsia|April 8, 2022
Ambient air pollution and epileptic seizures: A panel study in AustraliaZhuying Chen, Wenhua Yu, Rongbin Xu, et al.
Cell Surface (Amsterdam, Netherlands)|August 4, 2020
The interaction with fungal cell wall polysaccharides determines the salt tolerance of antifungal plant defensinsMark R Bleackley, Charlotte S Dawson, Jennifer A E Payne, et al.
Nature Chemical Biology|May 15, 2023
Single-cell multi-omics in the medicinal plant Catharanthus roseusChenxin Li, Joshua C Wood, Anh Hai Vu, et al.
Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.
Molecular Pharmacology|April 15, 2009
KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerizationKent T Symons, Mark E Massari, Phan M Nguyen, et al.
Medchemcomm|August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokineticsD C Pryde, N A Swain, P A Stupple, et al.
Nature Communications|October 26, 2021
Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureusJennifer A E Payne, Julien Tailhades, Felix Ellett, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2008
Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitorJoseph E Payne, Céline Bonnefous, Christian A Hassig, et al.
Obstetrics and Gynecology|December 8, 2016
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled TrialPeter F Schnatz, Xuezhi Jiang, Aaron K Aragaki, et al.
Eclinicalmedicine|August 13, 2021
Seizure likelihood varies with day-to-day variations in sleep duration in patients with refractory focal epilepsy: A longitudinal electroencephalography investigationKatrina L Dell, Daniel E Payne, Vaclav Kremen, et al.
Pageof 45

Showing results (411-420 of 441) with videos related to

Sort By:
Pageof 45
Epilepsia|April 8, 2022
Ambient air pollution and epileptic seizures: A panel study in AustraliaZhuying Chen, Wenhua Yu, Rongbin Xu, et al.
Cell Surface (Amsterdam, Netherlands)|August 4, 2020
The interaction with fungal cell wall polysaccharides determines the salt tolerance of antifungal plant defensinsMark R Bleackley, Charlotte S Dawson, Jennifer A E Payne, et al.
Nature Chemical Biology|May 15, 2023
Single-cell multi-omics in the medicinal plant Catharanthus roseusChenxin Li, Joshua C Wood, Anh Hai Vu, et al.
Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.
Molecular Pharmacology|April 15, 2009
KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerizationKent T Symons, Mark E Massari, Phan M Nguyen, et al.
Medchemcomm|August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokineticsD C Pryde, N A Swain, P A Stupple, et al.
Nature Communications|October 26, 2021
Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureusJennifer A E Payne, Julien Tailhades, Felix Ellett, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2008
Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitorJoseph E Payne, Céline Bonnefous, Christian A Hassig, et al.
Obstetrics and Gynecology|December 8, 2016
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled TrialPeter F Schnatz, Xuezhi Jiang, Aaron K Aragaki, et al.
Eclinicalmedicine|August 13, 2021
Seizure likelihood varies with day-to-day variations in sleep duration in patients with refractory focal epilepsy: A longitudinal electroencephalography investigationKatrina L Dell, Daniel E Payne, Vaclav Kremen, et al.
Pageof 45